NDC 68180-286 – Abacavir, Lamivudine And Zidovudine
Lamivudine 150 mg/1; Zidovudine 300 mg/1; Abacavir Sulfate 300 mg/1 · Tablet · Oral
Product NDC68180-286
Product details
- Brand name
- Abacavir, Lamivudine And Zidovudine
- Generic name
- Abacavir , Lamivudine And Zidovudine
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA202912
- Marketed since
- December 17, 2013
- Listing expires
- December 31, 2026
- Pharmacologic class
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor
Active ingredients
- Lamivudine 150 mg/1
- Zidovudine 300 mg/1
- Abacavir Sulfate 300 mg/1
Uses, dosage, side effects and warnings for Abacavir, Lamivudine And Zidovudine →
Package NDC codes (0)
| Package NDC | Description | Since |
|---|